🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

The real implications of this impressive work is to why we make these autoAbs? This supports a physiological role Casanova Lab Transient anti-IFN autoantibodies in the airways are associated with recovery from COVID-19 | Science Translational Medicine science.org/doi/10.1126/sc…

Previous work by PJ Utz et Al revealed autoABs after critical illness in non infected pts- reminiscent of Jerne network theory and Tx/Bx cells per Prof. Akiko Iwasaki Ruslan Medzhitov #Covid_19 is making us rethink immunology Alfred Kim (moving to Bluesky as alhkim) Max Konig

Chef Laureates!

Trilled to share our study "Disease-associated B cells and immune endotypes shape adaptive immune responses to SARS-CoV-2 mRNA vaccination in human SLE" just out today! rdcu.be/dZWI9 nature.com/articles/s4159…

Important study on human B-cell responses in SLE now Nature Immunology by our collaborators Katia Elisa Faliti and Sanz Lab. Congrats Katia!

A nasal swab could determine COVID severity trib.al/73jlCsK

Thanks for covering our study!

Out today in Immunity! We define how sialylation of IgG Fc domains regulates NF-κB-driven responses in the lungs. sciencedirect.com/science/articl… Stanford Medicine HHMI NIAID CIVICs

¿Cómo pueden los autoanticuerpos dirigidos contra el mismo objetivo ser a la vez dañinos o protectores?🤯 El autor principal de este complejo, pero asombroso trabajo es Eliver Ghosn y dice Jeroen den Dunnen que puede que sea el mejor artículo sobre inmunología del año #COVID19 Va🧵

A longitudinal study of #COVID19 patients shows anti-IFN-alpha #autoantibodies in the mucosa correlate with milder cases and better recovery, challenging the notion that these antibodies are solely a marker of severe disease. Eliver Ghosn Benjamin Babcock bit.ly/3YYTLRC

Thanks, Allen Siegler, for this great report on our study. We hope to find a pharmaceutical company partner to implement #FlowBEAT as a predictive diagnostic test. healthbeat.org/atlanta/2024/1…

✨ Ever wondered why B cells are so fond of IL-2? Wonder no more! Our study is finally published!🔍📑 authors.elsevier.com/c/1kAq43qNrUxu…

Just in time for #ASH24, our latest is online: nature.com/articles/s4159…

It is beautiful out here in Atlanta! 🌨️❄️Somehow, we will make it to Emory for the 2pm PhD defense of Ben Babcock 🎉! Join us via Zoom to hear Ben's important and surprising findings on the protective role of nasal autoantibodies in COVID-19! Ghosn Laboratory #BYourcell

Yes, here is the flyer!

He is now Dr. Babcock! Beautiful PhD defense (under heavy snow) Ben presented his surprising findings on the seemingly protective role of nasal autoantibodies in COVID19. And his work developing multi-omic scRNAseq to study human B cells! Well-deserved PhD! Ghosn Laboratory #BYourCell

Here's Benjamin Babcock celebrating after his fantastic defense!

This has been needed for a long time! Redefining obesity A new report of The Lancet Diabetes & Endocrinology commission that overrides current BMI categories and better defines features and pathophysiologic consequences of pre-clinical and clinical obesity thelancet.com/journals/landi… open-access (such as